Mrs. Stephanie Allard Chiappa, APRN Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: 950 Campbell Ave, West Haven, CT 06516 Phone: 203-932-5711 |
Mr. Muiz Abdul Latif, PA Physician Assistant - Surgical Medicare: Medicare Enrolled Practice Location: 950 Campbell Ave, Surgical Service/112, West Haven, CT 06516 Phone: 203-932-5711 Fax: 203-937-3845 |
Mr. Donald Francis Dailey, PA Physician Assistant - Medical Medicare: Not Enrolled in Medicare Practice Location: 950 Campbell Ave, West Haven, CT 06516 Phone: 203-932-5711 |
Benjamin T Gilbert, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 500 Elm St, West Haven, CT 06516 Phone: 203-223-3511 |
Mr. John Albert Leach, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: West Haven Veteran's Hospital, 950 Campbell Avenue, West Haven, CT 06516 Phone: 203-932-5711 Fax: 203-867-7600 |
News Archive
Universal Detection Technology, a developer of early-warning monitoring technologies and counter-terrorism training programs to protect people from bioterrorism and other infectious health threats, announced today that it will showcase the latest developments in bio-weapons detection technology, including the TS-10-5-agent biodetection kit, with live training kit demos at Milipol Paris 2009.
Using a topical application of the antioxidant ellagic acid, researchers at Hallym University in the Republic of Korea markedly prevented collagen destruction and inflammatory response - major causes of wrinkles - in both human skin cells and the sensitive skin of hairless mice following continuing exposure to UV-B, the sun's skin-damaging ultraviolet radioactive rays.
According to a new study children suffering from muscular dystrophy, cerebral palsy and other such conditions, have a much higher risk of severe complications from influenza, re-affirming the need for them to be vaccinated each year.
There are several challenges to be overcome if therapeutic anticancer vaccines, which are designed to boost the patient's anticancer immune response, are to be successfully developed. For example, the viruses used to deliver the tumor protein to the patient's immune system are themselves targeted by the patient's immune system, inducing neutralizing and suppressive responses. But now, a team of researchers, led by Michael Morse, at Duke University Medical Center, Durham, has developed a way to overcome these neutralizing and suppressive responses by using an alphavirus packaged in virus-like replicon particles.
› Verified 9 days ago